所有图片(1)
About This Item
经验公式（希尔记法）:
C15H11FN2
CAS号:
分子量:
238.26
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77
推荐产品
![2,4-Dichlorothieno[3,2-d]pyrimidine AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/408/704/0886c958-6ca7-40e3-91c0-ecc81fbfe483/640/0886c958-6ca7-40e3-91c0-ecc81fbfe483.png)
质量水平
方案
≥98% (HPLC)
表单
powder
颜色
white to beige
溶解性
DMSO: ≥10 mg/mL
储存温度
2-8°C
SMILES字符串
Fc1ccc2c(\C=C\c3cccnc3)c[nH]c2c1
InChI
1S/C15H11FN2/c16-13-5-6-14-12(10-18-15(14)8-13)4-3-11-2-1-7-17-9-11/h1-10,18H/b4-3+
InChI key
YBSDQTBCNYWBMX-ONEGZZNKSA-N
应用
680C91可用于：
- 作为色氨酸 2,3 双加氧酶（TDO）抑制剂，研究其对长鳍近海鱿鱼胚胎色素沉积的影响
- 作为 TDO 抑制剂，研究其在异种移植瘤实验中对食管鳞状细胞癌的影响
- 作为色氨酸 2,3 双加氧酶 2 （TDO2）抑制剂，研究其对人胚胎肾细胞毒性片段形成的影响
生化/生理作用
680C91 对单胺氧化酶 A 和 B、吲哚胺 2,3-双加氧酶和 5-羟色胺（5-HT）摄取以及 5-HT1A、1D、2A 和 2C 受体无抑制作用。
680C91 是色氨酸 2,3-双加氧酶（TDO）的有效抑制剂。
680C91 是色氨酸 2,3-双加氧酶（TDO）的有效抑制剂，该酶可指导色氨酸转化为犬尿氨酸。最近，犬尿氨酸被鉴定为芳烃受体（AHR）的内源性配体。TDO 在神经胶质瘤细胞中高表达，并有助于 AHR 介导的神经胶质瘤细胞存活并抑制抗肿瘤免疫反应。
警示用语：
Danger
危险声明
危险分类
Eye Dam. 1
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
历史批次信息供参考:
分析证书(COA)
Lot/Batch Number
M Salter et al.
Biochemical pharmacology, 49(10), 1435-1442 (1995-05-17)
The effects of a novel inhibitor 680C91 ((E)-6-fluoro-3-[2-(3- pyridyl)vinyl]-1H-indole) of the key enzyme of tryptophan catabolism tryptophan 2,3-dioxygenase (TDO) (EC 1.13.11.11), were examined on tryptophan catabolism in vitro and in vivo and on brain levels of tryptophan, serotonin (5-HT) and
Tryptophan 2, 3-dioxygenase 2 controls M2 macrophages polarization to promote esophageal squamous cell carcinoma progression via AKT/GSK3 beta IL-8 signaling pathway
Zhao Y, et al.
Acta Pharmaceutica Sinica. B (2021)
Karthyayani Rajamani et al.
Neuropharmacology, 117, 434-446 (2017-02-23)
Spinocerebellar ataxia type 3 or Machado-Joseph disease (SCA3/MJD) is characterized by the repetition of a CAG codon in the ataxin-3 gene (ATXN3), which leads to the formation of an elongated mutant ATXN3 protein that can neither be denatured nor undergo
Different effects of tryptophan 2,3-dioxygenase inhibition on SK-Mel-28 and HCT-8 cancer cell lines.
Sara Paccosi et al.
Journal of cancer research and clinical oncology, 146(12), 3155-3163 (2020-08-11)
Indoleamine 2,3-dioxygenase-1 (IDO1) and more recently, tryptophan 2,3-dioxygenase (TDO), are tryptophan-catabolizing enzymes with immunoregulatory properties in cancer. IDO1 is more expressed than TDO in many tumours including melanomas; however, IDO inhibitors did not give expected results in clinical trials, highlighting
Tryptophan 2, 3-dioxygenase 2 controls M2 macrophages polarization to promote esophageal squamous cell carcinoma progression via AKT/GSK3 beta IL-8 signaling pathway
Zhao Y, et al.
Acta pharmaceutica Sinica. B (2021)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门